Initial Benefits. Maverick agrees that, as of the Series B Closing Date, it will provide employee benefits (including welfare benefits and severance) that are substantially comparable in the aggregate to those provided in the aggregate to the Transferred Employees immediately prior to the Closing Date (but without being required to take into account any equity-related, retention, deal bonus, or other compensation related to or affected by the transactions contemplated by this Agreement). [ ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
Appears in 2 contracts
Sources: Asset Transfer Agreement (Harpoon Therapeutics, Inc.), Asset Transfer Agreement (Harpoon Therapeutics, Inc.)